Magnum Medical Finland

What Magnum Medical Finland does

Magnum Medical Finland Oy is a Finnish pharmaceutical wholesaler founded in 2004 and headquartered in Vantaa. The company received its Finnish pharmaceutical wholesale license from Fimea in July 2006, which authorises distribution of human medicines within Finland and underpins its regulated operating model. It distributes pharmaceuticals, hospital goods, nutritional supplements and veterinary products to pharmacies, hospitals, veterinary clinics and trade customers across Finland. The company is wholly owned by Magnum Group, the leading pharmaceutical wholesaler and retailer in the Baltic States, and the Finnish operation sits within that group's wider distribution footprint.

The company's core platform is a B2B wholesale and logistics business supported by an electronic ordering webshop (tilaukset.magnummedical.fi) that provides product availability and shelf-life information to healthcare buyers. The technology stack is conventional for regulated pharmaceutical wholesale: catalog-driven e-commerce on top of licensed distribution operations, audited quality systems published via the Oiva register, and last-mile delivery executed in part through Postnord for routes including Kotka and Rovaniemi. Distribution partnerships with major industry players anchor the business: Orion Oyj (distribution of approximately 100 generic cardiac and diabetes products from January 2018), THL (national vaccination programme support from November 2020) and Nextmune (veterinary specialty products from January 2026).

The business model is transaction-fee B2B wholesale: revenue is earned on the gross-to-net spread between acquisition cost of pharmaceuticals and the wholesale price to pharmacies, hospitals and veterinary clinics. Revenue is diversified across customer segments — primary in pharmacies and hospitals, secondary in veterinary and consumer health through pharmacy retail — and across product categories, reducing reliance on any single supplier or buyer line. In May 2026 the company announced a strategic refocus: it divested its Finnish brand-representation activities and launched a new corporate webshop, sharpening the franchise around its regulated wholesale and logistics core.

Name

Magnum Medical Finland

Legal name

Magnum Medical Finland Oy

Website

https://magnummedical.fi

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Magnum Medical Finland Oy is a Vantaa-based pharmaceutical wholesaler serving pharmacies, hospitals, and veterinary clinics across Finland as a subsidiary of Magnum Group, the Baltic States' leading pharmaceutical wholesale and retail group.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale & Distribution

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAIAJAO

Compounding Ingredient & API Distributors (Pharma Supply)

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

• Pharmaceutical wholesale
• Medical supply distribution
• Hospital pharmacy supply
• Veterinary pharmaceuticals
• Pharmaceutical logistics

Headquarters

HQ city

Vantaa

HQ country

Finland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical wholesale distribution: Core revenue from wholesale distribution of pharmaceuticals and health products to pharmacies, hospitals, and veterinary clinics across Finland. The company operates as a licensed pharmaceutical wholesaler serving healthcare professionals.
2. Health product marketing: Marketing selected healthcare equipment, supplies, and nutritional supplements to healthcare professionals and consumers.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels3 records

Core offering

Magnum Medical Finland Oy is a licensed pharmaceutical wholesaler that distributes medications, healthcare equipment, nutritional supplements, and veterinary products to pharmacies, hospitals, and veterinary clinics across Finland. The company operates country-wide logistics and an electronic ordering webshop that provides product availability and shelf-life information, and also handles special-permit medication importation for hospitals. It is part of Magnum Group, the leading pharmaceutical wholesaler and retailer in the Baltic States.

Product overview

Magnum Medical Finland Oy is a pharmaceutical wholesaler operating in Finland as part of the Magnum Group (Baltic States' leading pharmaceutical wholesaler and retailer). The company operates a core pharmaceutical wholesale and logistics business distributing medications and health products to pharmacies, hospitals, veterinary clinics, and retail consumers across Finland. The product portfolio includes: (1) the core pharmaceutical wholesale and logistics service for medications, (2) an electronic Webshop/Verkkopalvelu platform for online ordering with availability and shelf-life information, (3) healthcare equipment and supplies for hospitals, (4) nutritional supplements and consumer health products, and (5) veterinary products including pharmaceuticals and pet care items. The company received Finnish pharmaceutical wholesale rights in July 2006.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Wholesale and Logistics (Lääkkeiden tukkumyynti ja logistiikka) Core pharmaceutical wholesaling and logistics service distributing medications and health products to pharmacies, hospitals, and veterinary clinics across Finland on a country-wide basis.
• Verkkopalvelu (Online Service / Webshop)

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Partnerships

Six partnerships are on record, tiered minor and core.

• NextmuneminorChannel Partner/ Reseller/ Distributor · 15 January 2026Distribution partnership for Nextmune products announced in January 2026.
• PostnordminorChannel Partner/ Reseller/ Distributor · 27 November 2025Distribution partner for deliveries, with route changes announced for Rovaniemi route starting October 20, 2025 and Kotka area starting April 15, 2025.
• THL (Terveyden ja hyvinvoinnin laitos / Finnish Institute for Health and Welfare)coreStrategic or Co-development Partner · 20 November 2020Collaboration for distributing national seasonal influenza vaccines as part of the national vaccination program, distributing vaccines across Finland during autumn 2020.
• Orion OyjcoreStrategic or Co-development Partner · 24 January 2018Distribution partnership expanded in January 2018 to cover 100 generic cardiac and diabetes products. Initially had 41 products under distribution, with new products added in subsequent weeks. Partnership extended to cover at least 2018.
• Medans OyminorGTM or Marketing Partner · 26 April 2017Marketing partnership for Vivomixx lactic acid bacteria products. Joint promotion at Apteekkaripäivät 2017 pharmacy exhibition with product giveaways and contests.
• Magnum GroupcoreOthersParent company - Baltic region's leading pharmaceutical wholesaler and retailer. Operations span Finland, Estonia, Latvia, and Lithuania. Core principles include flexible and customer-oriented operations, fast and reliable distribution services, and innovative ICT solutions.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Magnum Group Latvia: Sister entity within Magnum Group distributing pharmaceuticals and health products in Latvia; identical business model, group ICT platform, and customer segmentation to Magnum Medical Finland.
• Tamro (Phoenix Group): Major pharmaceutical wholesaler in Finland and a direct competitor, owned by Phoenix Group; serves pharmacies, hospitals, and veterinary customers with a similar product mix to Magnum Medical Finland.
• Oriola Oyj: Finland's largest pharmaceutical wholesaler and a primary direct competitor to Magnum Medical Finland in distributing prescription medicines, consumer health products, and pharmacy supplies across Finland with nationwide logistics.
• Magnum Group Lithuania: Lithuanian sister entity of Magnum Group with the same pharmaceutical wholesale and retail model as Magnum Medical Finland; provides a direct regional benchmark for Finnish operations.
• Magnum Group Estonia: Sister company within Magnum Group operating pharmaceutical wholesale and retail in Estonia under the same parent platform; highly comparable in business model, customer segments, and product portfolio to Magnum Medical Finland.

Broad incumbents

• Alliance Healthcare (Walgreens Boots Alliance): European pharmaceutical wholesaler and pharmacy operator owned by Walgreens Boots Alliance; provides a useful comparable on European-wide distribution networks and pharmacy-channel integration.
• McKesson Corporation: Global pharmaceutical distribution and healthcare services giant; broad incumbent in pharmaceutical wholesale whose scale and digital capabilities define the competitive ceiling for regional players like Magnum Medical Finland.
• Phoenix Group AG: European pharmaceutical distribution leader and parent of Tamro; the relevant comparison for group-level scale, cross-border procurement leverage, and ICT platform investment that Magnum Medical Finland could access through its own parent group.
• Cencora (formerly AmerisourceBergen): One of the world's largest pharmaceutical distributors with global operations; relevant as a benchmark for distribution scale, technology investment, and competitive intensity in pharmaceutical wholesale.

Regional players

• OneMed Group: Nordic medical supplies and devices distributor active in Finland and neighboring countries; relevant peer in the medical device and consumables segment of Magnum Medical Finland's portfolio, though geographically broader and product-narrower.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Magnum Medical Finland